IPO Watch

Genome sequencing play Pacific Biosciences Inc. and cardiovascular company Aegerion Pharmaceuticals Inc. updated their S1s last week in preparation for IPO road shows:

Pacific Bio hopes to sell 12.5 million shares at $15-$17. A $16 price would raise $200 million and value the company at $817.8 million. The prior Friday, the company amended its IPO to raise up to $230 million...